Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Development and validation of a potential salivary biomarker panel for Oral Squamous Cell Carcinoma

View ORCID ProfileAnu Jain, Chinmaya Narayana Kotimoole, Sushmita Ghoshal, Jaimanti Bakshi, Aditi Chatterjee, Thottethodi Subrahmanya Keshav Prasad, View ORCID ProfileArnab Pal
doi: https://doi.org/10.1101/2020.06.08.20125054
Anu Jain
aDepartment of Biochemistry, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anu Jain
Chinmaya Narayana Kotimoole
bCentre for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, 575018, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sushmita Ghoshal
cDepartment of Radiotherapy, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaimanti Bakshi
dDepartment of Otolaryngology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aditi Chatterjee
eInstitute of Bioinformatics, International Technology Park, Bangalore, 560066, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thottethodi Subrahmanya Keshav Prasad
bCentre for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, 575018, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnab Pal
aDepartment of Biochemistry, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arnab Pal
  • For correspondence: pal.arnab@pgimer.edu.in
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Purpose Oral Squamous Cell Carcinoma (OSCC) is one of the most prevalent cancers in the world with maximum number of cases reported from India. Poor survival rate associated with OSCC can be attributed to non-availability of a biomarker, as one of the major reasons, leading to late presentation. Identification of an early diagnostic biomarker, which can also be used as a screening tool, will be helpful in reducing the disease morbidity and mortality.

Experimental Design In this article we report Parallel Reaction Monitoring (PRM) based validation of 12 candidate proteins, identified initially by TMT tag based relative quantification of salivary proteins on LC-MS, in the saliva of Oral Squamous Cell Carcinoma (OSCC) cases (N=50) and healthy controls (N=49), AZGP1, AHSG, KRT6C, S100A7, S100A9, KLK1, BPIFB2, IGLL5, CORO1A, LACRT, LCN2 and PSAP. Heavy isotope labelled reference peptides were used to produce calibration curve and absolute quantification of proteins and resulting data was analyzed statistically using R.

Results Salivary AHSG (p=0.0041**) and KRT6C (p=0.002**) were significantly upregulated in OSCC cases while AZGP1 (p=<0.0001***), KLK1 (p=0.006**) and BPIFB2 (p=0.0061**) were significantly downregulated. Multivariate logistic regression modelling resulted in a risk prediction model consisting of AZGP1, AHSG and KRT6C with p value <0.0001***. Using this model ROC with area under the curve of 82.2% was produced and sensitivity and specificity observed for this model was 78% and 73.5%. Positive and negative predictive values for the model were 76% and 75% respectively.

Conclusion We report a potential biomarker panel consisting of proteins AZGP1, AHSG and KRT6C for early diagnosis of OSCC.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Department of Science and Technology- Science and Engineering Research Board (DST-SERB), New Delhi, (EMR/2016/003253) and Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India (71/2-Edu-15/128 & 71/2-Edu-16/4844-45). Indian Council of Medical Research (ICMR), New Delhi, India provided fellowship to Anu Jain [3/1/3/JRF-HRD-022 (10519)].

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Institutional Ethics Committee at the Post Graduate Institute of Medical Education and Research, Chandigarh.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • jainanu1291{at}gmail.com, chinnu.kemmaai{at}gmail.com, rtsushmita{at}gmail.com, drjayabakshi{at}gmail.com, aditixchatterjee{at}gmail.com, keshav{at}yenepoya.edu.in, pal.arnab{at}pgimer.edu.in, Phone no: +91-9530801817, +91-172-2755177, Grants Department of Science and Technology- Science and Engineering Research Board (DST-SERB), New Delhi, (EMR/2016/003253), Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India (71/2-Edu-15/128 & 71/2-Edu-16/4844-45)., Indian Council of Medical Research (ICMR), New Delhi, India provided fellowship to Anu Jain [3/1/3/JRF-HRD-022 (10519)].

Data Availability

Data will be available upon request from the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted June 09, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Development and validation of a potential salivary biomarker panel for Oral Squamous Cell Carcinoma
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Development and validation of a potential salivary biomarker panel for Oral Squamous Cell Carcinoma
Anu Jain, Chinmaya Narayana Kotimoole, Sushmita Ghoshal, Jaimanti Bakshi, Aditi Chatterjee, Thottethodi Subrahmanya Keshav Prasad, Arnab Pal
medRxiv 2020.06.08.20125054; doi: https://doi.org/10.1101/2020.06.08.20125054
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Development and validation of a potential salivary biomarker panel for Oral Squamous Cell Carcinoma
Anu Jain, Chinmaya Narayana Kotimoole, Sushmita Ghoshal, Jaimanti Bakshi, Aditi Chatterjee, Thottethodi Subrahmanya Keshav Prasad, Arnab Pal
medRxiv 2020.06.08.20125054; doi: https://doi.org/10.1101/2020.06.08.20125054

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8789)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1863)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (492)
  • Hematology (207)
  • HIV/AIDS (394)
  • Infectious Diseases (except HIV/AIDS) (10565)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1756)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (265)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1845)
  • Public and Global Health (3986)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)